medigraphic.com
ENGLISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2008, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2008; 7 (4)


Phytopharmacological evaluation of Byesukar for hypoglycaemic activity and its effect on lipid profile and hepatic enzymes of glucose metabolism in diabetic rats

Guruvayoorappan C, Sudha G
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 39
Paginas: 358-363
Archivo PDF: 110.37 Kb.


PALABRAS CLAVE

Sin palabras Clave

FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Scheen JA. Drug treatment of non-insulin dependent diabetes mellitus in the 1990s. Achievements and future development. Drug 1997; 54: 355-368.

  2. Seifter S, England S. Energy metabolism, In: Arias I, Popper H, Schacter D, et al. (Eds). The Liver: Biology and Pathobiology. Rauen Press, New York. 1982; 219-249.

  3. Sochor M, Baquer NZ, McLean P. Glucose over and under utilization in diabetes: Comparative studies on the change in activities of enzymes of glucose metabolism in rat kidney and liver. Mol Physiol 1985: 51-68.

  4. Baquer NZ. Glucose over utilization and under utilization in diabetes and effects of antidiabetic compounds. Ann Real Acad Farm 1998; 64: 147-180.

  5. Tiwari AK, Madhusudana Rao J. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Curr Sci 2002; 83: 30-38.

  6. Bhattaram VA, Ceraefe M, Kohlest C, Vest M, Deundorf H. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomed 2002; 9: 1-36.

  7. Bailey CJ, Day C. Traditional treatments for diabetes. Diabetes Care 1989; 12: 553-564.

  8. Mitra SK, Gopumadhavan S, Muralidhar TS, Anturlikar SD, Sujatha MB. Effect of a herbomineral preparation D-400 in streptozotocin induced diabetic rats. J Ethnopharmacol 1996; 54: 41-46.

  9. Bhattacharya SK, Satyan KS, Chakrbarti A. Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol 1997; 35: 297-299.

  10. Annapurna A, Kanaka, Mahalakshmi D, Murali Krishna K. Antidiabetic activity of a polyherbal preparation (tincture of punchparna) in normal and diabetic rats. Indian J Exp Biol 2001; 39: 500-502.

  11. The WHO Expert Committee on diabetes mellitus. Technical report series 646. World Health Organization, Geneva 1980: 61.

  12. Pari L, Ramakrishnan R, Venkateswarn S. Antihyperglycaemic effect of Diamed, an herbal formulation in experimental diabetes in rats. J Pharm Pharmacol 2001; 53: 1139-1143.

  13. Pari L, Saravanan G. Antidiabetic effect of coagent db, a herbal drug in alloxan induced diabetes mellitus. Comp Biochem Physiol Part C 2002; 131: 19-25.

  14. Subash Babu P, Prince PSM. Antihyperglycemic and antioxidant effect of hyponidd an ayurvedic herbomineral formulation in streptozotocin induced diabetic rats. J Pharm Pharmacol 2004; 56: 1435-1442.

  15. Saravanan R, Pari L. Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats. BMC Complement Altern Med 2005; 5: 14.

  16. Guruvayoorappan C, Sudha G. Antioxidant potential of Byesukar, a polyherbal formulation on alloxan induced oxidative stress in rats. Malaysian J Biochem Mol Biol 2005; 11: 31-35.

  17. Folch J, Lees M, Solane SGH. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.

  18. Zlatkis A, Zak B, Boyle GJ. A method for the determination of serum cholesterol. J Clin Med 1953; 41: 486-492.

  19. Foster JB, Dunn RT. Stable reagents for determination of serum triglycerides by colorimetric condensation method. Clin Chim Acta 1973; 19: 338-340.

  20. Falholt K, Falholt W, Lund B. An easy colorimetric method for routine determination of free fatty acids in plasma. Clin Chim Acta 1973; 46: 105-111.

  21. Zilversmit BB, Davis AK. Microdetermination of plasma phospholipids by TCA precipitation. J Lab Clin Med 1950; 35: 155-161.

  22. Brandstrup N, Kirk JE, Bruni C. Determination of hexokinase in tissues. J Gerontol 1957; 12: 166-171.

  23. Koida H, Oda T. Pathological occurrence of glucose-6-phosphatase in liver disease. Clin Chem Acta 1959; 4: 554-561.

  24. Gancedo JM, Gancedo C. Fructose-1, 6-bis-phosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting yeast. Arch Microbiol 1971; 76: 132-138.

  25. Milgro FI, Martinez JA. Effect of the oral administration of a beta 3-adrenergic agonist on lipid metabolism in alloxan-diabetic rats. J Pharm Pharmacol 2000; 52: 851-856.

  26. Rajagopal K, Sasikala K. Antihyperglycaemic and antihyperlipidaemic effects of Nymphaea stellata in alloxan-induced diabetic rats. Singapore Med J 2008; 49(2): 137-141.

  27. Pari L, Maheswari JU. Hypoglycaemic effect of Musa sapientum L. in alloxan-induced diabetic rats. J Ethnopharmacol 1999; 68: 321-325.

  28. Gupta BL, Nehal M, Baquer NZ. Effect of experimental diabetes on the activities of hexokinase, glucose-6-phosphate dehydrogenase and catecholamines in rat erythrocytes of different ages. Indian J Exp Biol 1997; 35: 792-795.

  29. Seifter S, England S. Energy metabolism. In: The Liver: Biology and pathology. Arias I, Papper M, Schacter D (Ed.) Raven Press, New York 1982; 219-249.

  30. Baquer NZ. Glucose over utilization and under utilization in diabetes and and effects of antidiabetic compounds. Ann Renal Acad Farm 1998; 64: 147-180.

  31. Laakso M, Malkki M, Deeb SS. Amino acid substituents in hexokinase II among patients with NIDDM. Diabetes 1995; 44: 330-334.

  32. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper’s Biochemistry. 25th Ed. Stamford, Connecticut: Appleton and Lange. 2000: 610-617.

  33. Sharma SR, Dwivedi SK, Swarup D. Hypoglycemic and hypolipidaemic effects of Cinnamomum tomala nees leaves. Indian J Exp Biol 1996; 34: 372-374.

  34. Luo Q, Cai Y, Yan J, Sun M, Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci 2004; 76: 137-149.

  35. Goodman LS, Gilman A. The pharmacological basis of therapeutics. 7th Edition. Mac Millan, New York 1985; 1490-1510.

  36. Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP. Antidiabetic and antihyperlipaemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J Pharmacol 1997; 29: 162-167.

  37. Nageswara RG, Mahesh KP, Dhandapani VS, Rama KT, Hayashi T. Constituents of Cassia auriculata. Fitoterapia 2000; 71(1): 82-83.

  38. Timbola AK, Szpoganicz B, Branco A, Monache FD, Pizzolatti MG. A new flavanol from leaves of Eugenia jambolana. Fitoterapia 2002; 73(2): 174-176.

  39. Boonsri S, Karalai C, Ponglimanont C, Chantrapromma S, Kanjana-Opas A. Cytotoxic and antibacterial sesquiterpenes from Thespesia populnea. J Nat Prod 2008; 71(7): 1173-1177.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2008;7

ARTíCULOS SIMILARES

CARGANDO ...